SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-022244
Filing Date
2022-06-02
Accepted
2022-06-02 16:18:41
Documents
7
Effectiveness Date
2022-06-02

Document Format Files

Seq Description Document Type Size
1 S-8 xene-s8.htm S-8 131766
2 EX-5.1 xene-ex51_6.htm EX-5.1 8453
3 EX-23.1 xene-ex231_7.htm EX-23.1 3110
4 EX-FILING FEES xene-exfilingfees_8.htm EX-FILING FEES 24852
5 GRAPHIC g3cnghmyxgik000003.jpg GRAPHIC 5472
6 GRAPHIC g3cnghmyxgik000001.jpg GRAPHIC 14552
7 GRAPHIC g3cnghmyxgik000002.jpg GRAPHIC 28227
  Complete submission text file 0001564590-22-022244.txt   236072
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265377 | Film No.: 22991044
SIC: 2834 Pharmaceutical Preparations